Andreessen Horowitz
Listed as “Valar Labs”
- First observed:
- 1 Nov 2026
- Investment announced:
- Date not recorded
Stated aim: Valar Labs describes a vision for using AI with pathology slides.
Stated aim: Valar Labs describes a vision for using AI and pathology slides to inform decisions for physicians and patients.
Bio + Health
Category source ↗Checked
Some source history is available; coverage remains limited.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Valar Labs”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.